查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1937094

全球热疗癌症治疗市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Hyperthermia Cancer Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 149 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计热疗癌症治疗市场将从 2025 年的 2.5016 亿美元成长到 2034 年的 4.4958 亿美元，2026 年至 2034 年的复合年增长率为 6.73%。

受热疗作为癌症辅助性治疗的认知度不断提高的推动，热疗癌症治疗市场预计将显着增长。随着研究不断证实热疗能够增强放射线治疗和化疗的效果，医疗机构正越来越多地将这种治疗方法纳入其治疗通讯协定中。全球癌症发生率的上升，以及对创新微创治疗方法日益增长的需求，正在推动市场成长。此外，聚焦超音波和射频消融等技术的进步也提高了热疗的精准性和有效性。

治疗方法和监测技术的创新正在塑造热疗癌症治疗市场的未来前景。先进加热设备和技术的开发提高了靶向肿瘤的能力，同时最大限度地减少了对周围健康组织的损伤。此外，MRI 和电脑断层扫描等影像技术的整合使得在治疗过程中即时监测温度变化成为可能，从而确保最佳的治疗效果。随着研究不断探索热疗与其他癌症疗法的协同作用，预计市场将出现更多能够提高整体疗效的联合治疗通讯协定。

此外，随着製药公司和学术机构认识到热疗在癌症治疗中的潜力，加大对临床研发的投入将对热疗癌症治疗市场产生正面影响。肿瘤学家、研究人员和技术开发人员之间的合作对于推进临床试验和确保热疗的成功应用至关重要。在这种不断变化的环境下，监管机构有望简化创新热疗设备和治疗方法的核准流程，使癌症患者能够更快地获得有效的治疗方案。未来的重点将日益转向将热疗融入综合癌症治疗策略，强调个人化治疗方案和多学科协作在改善患者预后的重要性。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球热疗癌症治疗市场：依设备类型划分

  • 市场分析、洞察与预测
  • 微波热疗装置
  • 超音波热疗装置
  • 红外线热疗设备
  • 短波热疗装置

第五章：全球热疗癌症治疗市场：依应用划分

  • 市场分析、洞察与预测
  • 乳癌
  • 肝癌
  • 软组织肉瘤
  • 头颈部肿瘤
  • 摄护腺癌

第六章 全球热疗癌症治疗市场：依最终用户划分

  • 市场分析、洞察与预测
  • 医院
  • 诊所
  • 研究机构
  • 癌症中心

第七章 全球热疗癌症治疗市场：依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第九章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • CION Cancer Clinics
    • Combat Medical Ltd
    • First Baptist Medical Center
    • Haifu Medical Technology Co. Ltd
    • HCG Oncology
    • Hyperthermia Cancer Institute
    • Loyola Medicine
    • Novavida Integrative Medical Center
    • Pyrexar Medical
    • RanD Biotech SpA
    • Siteman Cancer Center
    • Sona Nanotech Inc
    • Verthermia
    • Zhongshan Hospital
简介目录
Product Code: VMR11215080

The Hyperthermia Cancer Treatment Market size is expected to reach USD 449.58 Million in 2034 from USD 250.16 Million (2025) growing at a CAGR of 6.73% during 2026-2034.

The hyperthermia cancer treatment market is poised for significant growth, driven by the increasing recognition of hyperthermia as a complementary therapy in cancer treatment. As research continues to demonstrate the efficacy of hyperthermia in enhancing the effectiveness of radiation and chemotherapy, healthcare providers are increasingly incorporating this modality into treatment protocols. The rising prevalence of cancer globally, coupled with the demand for innovative and less invasive treatment options, is propelling the market forward. Additionally, advancements in technology, such as focused ultrasound and radiofrequency ablation, are enhancing the precision and effectiveness of hyperthermia treatments.

Innovations in treatment delivery and monitoring are shaping the future of the hyperthermia cancer treatment market. The development of advanced heating devices and techniques is improving the ability to target tumors while minimizing damage to surrounding healthy tissues. Furthermore, the integration of imaging technologies, such as MRI and CT scans, is enabling real-time monitoring of temperature changes during treatment, ensuring optimal therapeutic outcomes. As research continues to explore the synergistic effects of hyperthermia with other cancer therapies, the market is likely to witness the introduction of combination treatment protocols that enhance overall efficacy.

Moreover, the hyperthermia cancer treatment market will benefit from increased investment in clinical research and development, as pharmaceutical companies and academic institutions recognize the potential of hyperthermia in cancer care. Collaborative efforts between oncologists, researchers, and technology developers will be essential in advancing clinical trials and ensuring the successful implementation of hyperthermia treatments. As the landscape evolves, regulatory bodies are expected to streamline approval processes for innovative hyperthermia devices and therapies, facilitating faster access to effective treatment options for cancer patients. The focus will increasingly shift towards integrating hyperthermia into comprehensive cancer care strategies, emphasizing the importance of personalized treatment plans and multidisciplinary approaches in improving patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

  • Microwave Hyperthermia Device
  • Ultrasound Hyperthermia Device
  • Infrared Hyperthermia Device
  • Short-wave Hyperthermia Device

By Application

  • Breast Cancer
  • Liver Cancer
  • Short Tissue Sarcoma
  • Head & Neck Tumor
  • Prostate Cancer

By End-User

  • Hospitals
  • Clinics
  • Research Institutes
  • Cancer Centers

COMPANIES PROFILED

  • CION Cancer Clinics, Combat Medical Ltd, First Baptist Medical Center, Haifu Medical Technology Co Ltd, HCG Oncology, Hyperthermia Cancer Institute, Loyola Medicine, Novavida Integrative Medical Center, Pyrexar Medical, RanD Biotech SpA, Siteman Cancer Center, Sona Nanotech Inc, Verthermia, Zhongshan Hospital

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Device Type
  • 4.2. Microwave Hyperthermia Device Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Ultrasound Hyperthermia Device Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Infrared Hyperthermia Device Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Short-wave Hyperthermia Device Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Liver Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Short Tissue Sarcoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Head & Neck Tumor Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Cancer Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Device Type
    • 7.2.2 By Application
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Device Type
    • 7.3.2 By Application
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Device Type
    • 7.4.2 By Application
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Device Type
    • 7.5.2 By Application
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Device Type
    • 7.6.2 By Application
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HYPERTHERMIA CANCER TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 CION Cancer Clinics
    • 9.2.2 Combat Medical Ltd
    • 9.2.3 First Baptist Medical Center
    • 9.2.4 Haifu Medical Technology Co. Ltd
    • 9.2.5 HCG Oncology
    • 9.2.6 Hyperthermia Cancer Institute
    • 9.2.7 Loyola Medicine
    • 9.2.8 Novavida Integrative Medical Center
    • 9.2.9 Pyrexar Medical
    • 9.2.10 RanD Biotech SpA
    • 9.2.11 Siteman Cancer Center
    • 9.2.12 Sona Nanotech Inc
    • 9.2.13 Verthermia
    • 9.2.14 Zhongshan Hospital